EKTA B Stock Overview
A medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Elekta AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 60.45 |
52 Week High | SEK 88.85 |
52 Week Low | SEK 58.20 |
Beta | 1.12 |
1 Month Change | -4.20% |
3 Month Change | -11.82% |
1 Year Change | -25.94% |
3 Year Change | -46.88% |
5 Year Change | -50.99% |
Change since IPO | 342.32% |
Recent News & Updates
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Dec 23Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Nov 18Recent updates
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Dec 23Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Nov 18We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
Nov 15Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Nov 01Elekta AB (publ) (STO:EKTA B) Screens Well But There Might Be A Catch
Oct 09Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Sep 24Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Sep 09Should Shareholders Reconsider Elekta AB (publ)'s (STO:EKTA B) CEO Compensation Package?
Aug 30Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 81% Above Its Share Price
Aug 28Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Aug 15Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns
Jun 19What Elekta AB (publ)'s (STO:EKTA B) P/E Is Not Telling You
May 24Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 12When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Apr 03Is Elekta (STO:EKTA B) A Risky Investment?
Mar 18Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Feb 22Why Investors Shouldn't Be Surprised By Elekta AB (publ)'s (STO:EKTA B) P/E
Feb 20Return Trends At Elekta (STO:EKTA B) Aren't Appealing
Feb 08Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 37% Above Its Share Price
Jan 03Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Dec 18Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Dec 01Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Nov 11Elekta (STO:EKTA B) Has Some Way To Go To Become A Multi-Bagger
Nov 09Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Oct 28Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?
Oct 26Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Oct 14An Intrinsic Calculation For Elekta AB (publ) (STO:EKTA B) Suggests It's 41% Undervalued
Sep 23Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Sep 08Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Aug 25Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Aug 10Is There Now An Opportunity In Elekta AB (publ) (STO:EKTA B)?
Jul 21Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Jul 08Is There An Opportunity With Elekta AB (publ)'s (STO:EKTA B) 25% Undervaluation?
Jun 13Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
May 28Here's Why Elekta (STO:EKTA B) Can Manage Its Debt Responsibly
Apr 02Investors Can Find Comfort In Elekta's (STO:EKTA B) Earnings Quality
Mar 04Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 27Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 15Elekta (STO:EKTA B) Will Pay A Larger Dividend Than Last Year At SEK1.20
Feb 01What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?
Jan 23These 4 Measures Indicate That Elekta (STO:EKTA B) Is Using Debt Reasonably Well
Dec 27Elekta's (STO:EKTA B) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Shareholder Returns
EKTA B | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 0.2% | 0.5% | -2.5% |
1Y | -25.9% | -7.7% | 4.4% |
Return vs Industry: EKTA B underperformed the Swedish Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: EKTA B underperformed the Swedish Market which returned 4.4% over the past year.
Price Volatility
EKTA B volatility | |
---|---|
EKTA B Average Weekly Movement | 4.1% |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.4% |
10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: EKTA B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: EKTA B's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 4,580 | Gustaf Salford | elekta.com |
Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software.
Elekta AB (publ) Fundamentals Summary
EKTA B fundamental statistics | |
---|---|
Market cap | SEK 23.10b |
Earnings (TTM) | SEK 1.00b |
Revenue (TTM) | SEK 17.72b |
23.1x
P/E Ratio1.3x
P/S RatioIs EKTA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EKTA B income statement (TTM) | |
---|---|
Revenue | SEK 17.72b |
Cost of Revenue | SEK 11.25b |
Gross Profit | SEK 6.48b |
Other Expenses | SEK 5.48b |
Earnings | SEK 1.00b |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
Feb 21, 2025
Earnings per share (EPS) | 2.62 |
Gross Margin | 36.55% |
Net Profit Margin | 5.65% |
Debt/Equity Ratio | 76.9% |
How did EKTA B perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield92%
Payout RatioDoes EKTA B pay a reliable dividends?
See EKTA B dividend history and benchmarksElekta dividend dates | |
---|---|
Ex Dividend Date | Mar 06 2025 |
Dividend Pay Date | Mar 12 2025 |
Days until Ex dividend | 71 days |
Days until Dividend pay date | 77 days |
Does EKTA B pay a reliable dividends?
See EKTA B dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 01:22 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/10/31 |
Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Elekta AB (publ) is covered by 40 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sumit Sayal | AlphaValue |
Alexander Kleban | Barclays |
Hassan Al-Wakeel | Barclays |